Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 68, n° 4S1
page AB20 (avril 2013)
Doi : 10.1016/j.jaad.2012.12.085
Aesthetic Dermatology

A multicenter, double-masked, placebo-controlled study assessing patient satisfaction with bimatoprost ophthalmic solution 0.03% for increasing eyelash prominence
 

Joel Cohen, MD, University of Colorado, Denver, CO, United States; Carrie Caulkins, PhD, Allergan, Inc, Irvine, CA, United States; Christine Somogyi, RN, Allergan, Inc, Irvine, CA, United States; Edwin Williams, MD, Titan Research and Development Group, Latham, NY, United States; Fredric Brandt, MD, Dermatology Research Institute, Coral Gables, FL, United States; Lawrence Green, MD, George Washington University, Washington, District of Columbia, United States; Ruth Tedaldi, MD, Dermatology Partners, Inc, Wellesley, MA, United States


 100% sponsored by Allergan, Inc


Top of the page

© 2013  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@